Global and China Anti-Hypertensive Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 24-Sep-2020
No. of pages: 125
Inquire Before Buying

Anti-Hypertensive Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Anti-Hypertensive Drugs market is segmented into

- Diuretics

- Angiotensin Converting Enzyme (ACE) Inhibitors

- Angiotensin Receptor Blockers (ARBs)

- Calcium Channel Blockers

- Beta Blockers

- Alpha Blockers

- Vasodilators

- Renin Inhibitors

Segment by Application, the Anti-Hypertensive Drugs market is segmented into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Regional and Country-level Analysis

The Anti-Hypertensive Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Anti-Hypertensive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-Hypertensive Drugs Market Share Analysis

Anti-Hypertensive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Hypertensive Drugs business, the date to enter into the Anti-Hypertensive Drugs market, Anti-Hypertensive Drugs product introduction, recent developments, etc.

The major vendors covered:

- Novartis

- Pfizer

- Johnson & Johnson

- Sanofi

- Lupin

- Ranbaxy Laboratories

- Merck

- AstraZeneca

- Daiichi Sankyo Company Limited

- Takeda Pharmaceutical

Global and China Anti-Hypertensive Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Hypertensive Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type
1.4.2 Diuretics
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin Receptor Blockers (ARBs)
1.4.5 Calcium Channel Blockers
1.4.6 Beta Blockers
1.4.7 Alpha Blockers
1.4.8 Vasodilators
1.4.9 Renin Inhibitors
1.5 Market by Application
1.5.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Hypertensive Drugs Revenue 2015-2026
2.1.2 Global Anti-Hypertensive Drugs Sales 2015-2026
2.2 Global Anti-Hypertensive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Anti-Hypertensive Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Anti-Hypertensive Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Anti-Hypertensive Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Anti-Hypertensive Drugs Revenue Forecast by Region (2021-2026)
3 Global Anti-Hypertensive Drugs Competitor Landscape by Players
3.1 Global Top Anti-Hypertensive Drugs Sales by Manufacturers
3.1.1 Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Anti-Hypertensive Drugs Manufacturers by Revenue
3.2.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Hypertensive Drugs Revenue in 2019
3.2.5 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-Hypertensive Drugs Price by Manufacturers
3.4 Global Anti-Hypertensive Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Hypertensive Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Hypertensive Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Hypertensive Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Hypertensive Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Hypertensive Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Hypertensive Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Hypertensive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Hypertensive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Hypertensive Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Hypertensive Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Hypertensive Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Hypertensive Drugs Price by Application (2015-2020)
5.2 Anti-Hypertensive Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
6.1.1 China Anti-Hypertensive Drugs Sales YoY Growth 2015-2026
6.1.2 China Anti-Hypertensive Drugs Revenue YoY Growth 2015-2026
6.1.3 China Anti-Hypertensive Drugs Market Share in Global Market 2015-2026
6.2 China Anti-Hypertensive Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Anti-Hypertensive Drugs Players by Sales (2015-2020)
6.2.2 China Top Anti-Hypertensive Drugs Players by Revenue (2015-2020)
6.3 China Anti-Hypertensive Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Anti-Hypertensive Drugs Price by Type (2015-2020)
6.4 China Anti-Hypertensive Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Anti-Hypertensive Drugs Price Forecast by Type (2021-2026)
6.5 China Anti-Hypertensive Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Anti-Hypertensive Drugs Price by Application (2015-2020)
6.6 China Anti-Hypertensive Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
7.2 North America Anti-Hypertensive Drugs Market Facts & Figures by Country
7.2.1 North America Anti-Hypertensive Drugs Sales by Country (2015-2020)
7.2.2 North America Anti-Hypertensive Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
8.2 Europe Anti-Hypertensive Drugs Market Facts & Figures by Country
8.2.1 Europe Anti-Hypertensive Drugs Sales by Country
8.2.2 Europe Anti-Hypertensive Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Anti-Hypertensive Drugs Market Facts & Figures by Country
10.2.1 Latin America Anti-Hypertensive Drugs Sales by Country
10.2.2 Latin America Anti-Hypertensive Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anti-Hypertensive Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country
11.2.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Anti-Hypertensive Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Anti-Hypertensive Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Anti-Hypertensive Drugs Products Offered
12.4.5 Sanofi Recent Development
12.5 Lupin
12.5.1 Lupin Corporation Information
12.5.2 Lupin Description and Business Overview
12.5.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lupin Anti-Hypertensive Drugs Products Offered
12.5.5 Lupin Recent Development
12.6 Ranbaxy Laboratories
12.6.1 Ranbaxy Laboratories Corporation Information
12.6.2 Ranbaxy Laboratories Description and Business Overview
12.6.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products Offered
12.6.5 Ranbaxy Laboratories Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Description and Business Overview
12.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck Anti-Hypertensive Drugs Products Offered
12.7.5 Merck Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Anti-Hypertensive Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Daiichi Sankyo Company Limited
12.9.1 Daiichi Sankyo Company Limited Corporation Information
12.9.2 Daiichi Sankyo Company Limited Description and Business Overview
12.9.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products Offered
12.9.5 Daiichi Sankyo Company Limited Recent Development
12.10 Takeda Pharmaceutical
12.10.1 Takeda Pharmaceutical Corporation Information
12.10.2 Takeda Pharmaceutical Description and Business Overview
12.10.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products Offered
12.10.5 Takeda Pharmaceutical Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Anti-Hypertensive Drugs Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Hypertensive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Hypertensive Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Hypertensive Drugs Market Segments
Table 2. Ranking of Global Top Anti-Hypertensive Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Hypertensive Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diuretics
Table 5. Major Manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 6. Major Manufacturers of Angiotensin Receptor Blockers (ARBs)
Table 7. Major Manufacturers of Calcium Channel Blockers
Table 8. Major Manufacturers of Beta Blockers
Table 9. Major Manufacturers of Alpha Blockers
Table 10. Major Manufacturers of Vasodilators
Table 11. Major Manufacturers of Renin Inhibitors
Table 12. Global Anti-Hypertensive Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Anti-Hypertensive Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Anti-Hypertensive Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Anti-Hypertensive Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Anti-Hypertensive Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Anti-Hypertensive Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 18. Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Anti-Hypertensive Drugs Sales Share by Manufacturers (2015-2020)
Table 20. Global Anti-Hypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Anti-Hypertensive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Hypertensive Drugs as of 2019)
Table 22. Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Anti-Hypertensive Drugs Price (2015-2020) (USD/Pcs)
Table 25. Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Anti-Hypertensive Drugs Product Type
Table 27. Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 30. Global Anti-Hypertensive Drugs Sales Share by Type (2015-2020)
Table 31. Global Anti-Hypertensive Drugs Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Anti-Hypertensive Drugs Revenue Share by Type (2015-2020)
Table 33. Anti-Hypertensive Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 34. Global Anti-Hypertensive Drugs Sales Share by Type (2021-2026)
Table 35. Global Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 36. Global Anti-Hypertensive Drugs Sales Share by Application (2015-2020)
Table 37. Global Anti-Hypertensive Drugs Sales Share by Application (2021-2026)
Table 38. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Application (2021-2026)
Table 39. Global Anti-Hypertensive Drugs Revenue by Application (2015-2020) (US$ Million)
Table 40. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 41. China Anti-Hypertensive Drugs Sales (K Units) of Key Companies (2015-2020)
Table 42. China Anti-Hypertensive Drugs Sales Share by Company (2015-2020)
Table 43. China Anti-Hypertensive Drugs Revenue (US$ Million) by Company (2015-2020)
Table 44. China Anti-Hypertensive Drugs Sales (K Units) by Type (2015-2020)
Table 45. China Anti-Hypertensive Drugs Sales Share by Type (2015-2020)
Table 46. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 47. China Anti-Hypertensive Drugs Price (K Units) by Type (2015-2020)
Table 48. China Anti-Hypertensive Drugs Sales (K Units) by Type (2021-2026)
Table 49. China Anti-Hypertensive Drugs Sales Share by Type (2021-2026)
Table 50. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 51. China Anti-Hypertensive Drugs Revenue Share by Type (2021-2026)
Table 52. China Anti-Hypertensive Drugs Price (K Units) by Type (2021-2026)
Table 53. China Anti-Hypertensive Drugs Sales (K Units) by Application (2015-2020)
Table 54. China Anti-Hypertensive Drugs Sales Share by Application (2015-2020)
Table 55. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 56. China Anti-Hypertensive Drugs Sales (K Units) by Application (2021-2026)
Table 57. China Anti-Hypertensive Drugs Sales Share by Application (2021-2026)
Table 58. China Anti-Hypertensive Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 59. China Anti-Hypertensive Drugs Revenue Share by Application (2021-2026)
Table 60. North America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 61. North America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 62. North America Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. North America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 64. Europe Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 65. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 66. Europe Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 68. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2015-2020) (K Units)
Table 69. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020)
Table 70. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2015-2020) (US$ Million)
Table 71. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020)
Table 72. Latin America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 73. Latin America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 74. Latin Americaa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 76. Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 77. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 78. Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 79. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Novartis Anti-Hypertensive Drugs Product
Table 84. Novartis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Sanofi Product
Table 99. Sanofi Recent Development
Table 100. Lupin Corporation Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Lupin Product
Table 104. Lupin Recent Development
Table 105. Ranbaxy Laboratories Corporation Information
Table 106. Ranbaxy Laboratories Description and Business Overview
Table 107. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Ranbaxy Laboratories Product
Table 109. Ranbaxy Laboratories Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Merck Product
Table 114. Merck Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. AstraZeneca Product
Table 119. AstraZeneca Recent Development
Table 120. Daiichi Sankyo Company Limited Corporation Information
Table 121. Daiichi Sankyo Company Limited Description and Business Overview
Table 122. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Daiichi Sankyo Company Limited Product
Table 124. Daiichi Sankyo Company Limited Recent Development
Table 125. Takeda Pharmaceutical Corporation Information
Table 126. Takeda Pharmaceutical Description and Business Overview
Table 127. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Takeda Pharmaceutical Product
Table 129. Takeda Pharmaceutical Recent Development
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Anti-Hypertensive Drugs Players
Table 134. Anti-Hypertensive Drugs Customers List
Table 135. Anti-Hypertensive Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Hypertensive Drugs Product Picture
Figure 2. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Diuretics Product Picture
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
Figure 5. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 6. Calcium Channel Blockers Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Alpha Blockers Product Picture
Figure 9. Vasodilators Product Picture
Figure 10. Renin Inhibitors Product Picture
Figure 11. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Anti-Hypertensive Drugs Report Years Considered
Figure 16. Global Anti-Hypertensive Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Anti-Hypertensive Drugs Sales 2015-2026 (K Units)
Figure 18. Global Anti-Hypertensive Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Anti-Hypertensive Drugs Sales Market Share by Region in 2019
Figure 21. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Anti-Hypertensive Drugs Revenue Market Share by Region in 2019
Figure 23. Global Anti-Hypertensive Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Anti-Hypertensive Drugs Revenue in 2019
Figure 25. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2019
Figure 28. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Anti-Hypertensive Drugs Revenue Market Share by Type in 2019
Figure 30. Global Anti-Hypertensive Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2019
Figure 33. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Anti-Hypertensive Drugs Revenue Market Share by Application in 2019
Figure 35. China Anti-Hypertensive Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 36. China Anti-Hypertensive Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 37. China Anti-Hypertensive Drugs Market Share in Global Market 2015-2026
Figure 38. China 5 and 10 Largest Anti-Hypertensive Drugs Players Market Share by Revenue in Anti-Hypertensive Drugs in 2019
Figure 39. China Anti-Hypertensive Drugs Revenue Share by Type (2015-2020)
Figure 40. China Anti-Hypertensive Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 41. China Anti-Hypertensive Drugs Revenue Share by Application (2015-2020)
Figure 42. China Anti-Hypertensive Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 43. North America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. North America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. North America Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 46. North America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 47. U.S. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.S. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Canada Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Canada Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Europe Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 52. Europe Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 53. Europe Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 54. Europe Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 55. Germany Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Germany Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. France Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. France Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. U.K. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. U.K. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Italy Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Italy Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Russia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. Russia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Asia Pacific Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 66. Asia Pacific Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 67. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region in 2019
Figure 68. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region in 2019
Figure 69. China Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. China Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Japan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Japan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. South Korea Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. South Korea Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. India Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. India Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Australia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Australia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Taiwan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Taiwan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Indonesia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Indonesia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Thailand Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Thailand Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Malaysia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Malaysia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Philippines Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Philippines Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Vietnam Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Vietnam Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Latin America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 92. Latin America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 93. Latin America Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 94. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 95. Mexico Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Mexico Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Brazil Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 98. Brazil Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Argentina Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Argentina Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Middle East and Africa Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 102. Middle East and Africa Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Turkey Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. Saudi Arabia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 110. U.A.E Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Porter's Five Forces Analysis
Figure 112. Anti-Hypertensive Drugs Value Chain
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
  • Global Medical Cannabis Oil Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Medical Cannabis Oil market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Cannabis Oil business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cannabis Oil market by ......
  • Global Medical Use Empty Capsules Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Medical Use Empty Capsules market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Use Empty Capsules business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Use Empty C......
  • Global Systemic Lupus Erythematosus (SLE) Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the Systemic Lupus Erythematosus (SLE) Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Systemic Lupus Erythematosus (SLE) Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global Pets Vitamins and Supplements Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Pets Vitamins and Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pets Vitamins and Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pets Vitamins......
  • Global Soft Elastic Capsule Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the Soft Elastic Capsule market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Soft Elastic Capsule business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Soft Elastic Capsule market by ......
  • Global Anti-worm Medication Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 162
    According to this study, over the next five years the Anti-worm Medication market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-worm Medication business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-worm Medication market by ......
  • Global Albendazole Anthelmintic Drug Market Growth 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Albendazole Anthelmintic Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albendazole Anthelmintic Drug business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Albendazole A......
  • Global Immune System Supplements Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 138
    According to this study, over the next five years the Immune System Supplements market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Immune System Supplements business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Immune System Supplements market......
  • Global Antipyretic Analgesics Market Growth (Status and Outlook) 2020-2025
    Published: 20-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Antipyretic Analgesics market will register a 1.3%% CAGR in terms of revenue, the global market size will reach $ 2693.6 million by 2025, from $ 2561.5 million in 2019. In particular, this report presents the global revenue market share of key companies in Antipyretic Analgesics business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic Analgesics market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs